Original Research

Published on 13 Jul 2023

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Neslihan Cabioglu
Aysel Bayram
Selman Emiroglu
Semen Onder
Huseyin Karatay
Gizem Oner
Mustafa Tukenmez
Mahmut Muslumanoglu
Abdullah Igci
Adnan Aydiner

Frontiers in Oncology

doi 10.3389/fonc.2023.1165257

1,572 views
1 citation

Original Research

Published on 11 Jul 2023

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Hongxiang Liu
Yong Luo
Shankun Zhao
Jing Tan
Minjian Chen
Xihai Liu
Jianheng Ye
Shanghua Cai
Yulin Deng
Jinchuang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1202151

2,244 views
1 citation

Case Report

Published on 10 Jul 2023

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary

in Cancer Immunity and Immunotherapy

Risako Suzuki
Kazuyuki Hamada
Ryotaro Ohkuma
Mayumi Homma
Toshiaki Tsurui
Nana Iriguchi
Tomoyuki Ishiguro
Yuya Hirasawa
Hirotsugu Ariizumi
Yutaro Kubota

Frontiers in Oncology

doi 10.3389/fonc.2023.1231986

1,837 views

Editorial

Published on 07 Jul 2023

Editorial: Hallmark of cancer: tumor promoting inflammation

in Cancer Immunity and Immunotherapy

Luca Roncati
Carlos R. Figueiredo

Frontiers in Oncology

doi 10.3389/fonc.2023.1242407

2,084 views

Perspective

Published on 07 Jul 2023

B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers

in Cancer Immunity and Immunotherapy

Marco Ventin
Giulia Cattaneo
Luke Maggs
Jingyu Jia
Shahrzad Arya
Soldano Ferrone
Xinhui Wang
Cristina R. Ferrone

Frontiers in Oncology

doi 10.3389/fonc.2023.1193963

3,765 views
11 citations

Systematic Review

Published on 06 Jul 2023

Analysis of prognostic factors affecting immune checkpoint inhibitor therapy in tumor patients exposed to antibiotics

in Cancer Immunity and Immunotherapy

Qian Chen
Zhen Zhang
Xiaoli Li
Shaomei Feng
Shui Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1204248

1,206 views
1 citation

Case Report

Published on 04 Jul 2023

Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy

in Cancer Immunity and Immunotherapy

Yong-Guang Wei
Hao Su
Zi-li Lv
Xi-Wen Liao
Zhi-Ming Zeng
Yu-Xuan Jia
Hua-Sheng Huang
Xiao-Qiang Shen
Guang-Zhi Zhu
Chuang-Ye Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1165538

2,100 views
1 citation

Original Research

Published on 29 Jun 2023

Evaluation of the impacts of photodynamic therapy on the prognosis of patients with hrHPV infection based on BTNL8 expression

in Cancer Immunity and Immunotherapy

Hongqing Lv
Shuai Lou
Lin Zhang
Dawei Cui
Yao Li
Ying Yang
Meilan Chen
Pan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1218808

1,123 views

Case Report

Published on 23 Jun 2023

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use

in Cancer Immunity and Immunotherapy

Won Jin Jeon
Jin Hyun Moon
Bryan Pham
Bowon Joung
Laura Denham
Joel Brothers

Frontiers in Oncology

doi 10.3389/fonc.2023.1198292

1,829 views

Original Research

Published on 23 Jun 2023

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Mengxi Wu
Zhenyu Wu
Jun Yan
Jie Zeng
Jun Kuang
Chenghua Zhong
Xiaojia Zhu
Yijun Mo
Quanwei Guo
Dongfang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1198746

2,409 views
1 citation

Review

Published on 22 Jun 2023

You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis

in Cancer Immunity and Immunotherapy

Alyssa J. Cozzo
Michael F. Coleman
Stephen D. Hursting

Frontiers in Oncology

doi 10.3389/fonc.2023.1191332

2,302 views
1 citation

Original Research

Published on 20 Jun 2023

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape

in Cancer Immunity and Immunotherapy

Ankang Zhu
Dongchen Pei
Yan Zong
Yan Fan
Shuai Wei
Zhisong Xing
Shuailin Song
Xin Wang
Xingcai Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1199608

2,389 views
3 citations

Review

Published on 16 Jun 2023

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review

in Cancer Immunity and Immunotherapy

Huilan Zheng
Gang Wang
Ming Liu
Hongbin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1168226

4,285 views
6 citations

Editorial

Published on 16 Jun 2023

Editorial: Hallmark of cancer: avoiding immune suppression

in Cancer Immunity and Immunotherapy

Faris Q. B. Alenzi
Benedetta Apollonio
Liusheng Peng
Elias J. Sayour
Michal Sheffer

Frontiers in Oncology

doi 10.3389/fonc.2023.1211456

1,486 views

Review

Published on 16 Jun 2023

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

in Cancer Immunity and Immunotherapy

Lidia Gatto
Ilaria Ricciotti
Alicia Tosoni
Vincenzo Di Nunno
Stefania Bartolini
Lucia Ranieri
Enrico Franceschi

Frontiers in Oncology

doi 10.3389/fonc.2023.1206983

3,342 views
4 citations

Systematic Review

Published on 15 Jun 2023

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis

in Cancer Immunity and Immunotherapy

Muyesar Alifu
Min Tao
Xiao Chen
Jie Chen
Kejing Tang
Yubo Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1146905

3,417 views
7 citations

Navigation group

Articles

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary

Editorial: Hallmark of cancer: tumor promoting inflammation

B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers

Analysis of prognostic factors affecting immune checkpoint inhibitor therapy in tumor patients exposed to antibiotics

Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy

Evaluation of the impacts of photodynamic therapy on the prognosis of patients with hrHPV infection based on BTNL8 expression

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review

Editorial: Hallmark of cancer: avoiding immune suppression

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis